Paper29048985
Impact of meningococcal group B OMV vaccines, beyond their brief.
Petousis-Harris H. Hum Vaccin Immunother, 2018. Cited by 57 papers, by iCite.
Cite this record
ConductScience Library. Impact of meningococcal group B OMV vaccines, beyond their brief. Papers, record 29048985. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/29048985
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics16
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Antigens, Bacterial | Major topic |
| Bacterial Outer Membrane Proteins | Major topic |
| Meningococcal Infections | Major topic |
| Meningococcal Vaccines | Major topic |
| Neisseria meningitidis, Serogroup B | Major topic |
| Brazil | |
| Cross Protection | |
| Cuba | |
| Gonorrhea | |
| Humans | |
| Immunogenicity, Vaccine | |
| Incidence | |
| Neisseria gonorrhoeae | |
| New Zealand | |
| Recombinant Proteins | |
| Treatment Outcome |
Source PubMed
Comments and corrections1
PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.
| Kind | PMID | Title | In Papers |
|---|---|---|---|
| Comment in | 29420119 | Cross-protection induced by VA-MENGOC-BC® vaccine. | https://conductscience.org/library/papers/29420119 |
Source PubMed
References38
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 20219881 | Updated postlicensure surveillance of the meningococcal C conjugate vaccine in England and Wales: effectiveness, validation of serological correlates of protection, and modeling predictions of the duration of herd immunity. | Clin Vaccine Immunol | 2010 | https://conductscience.org/library/papers/20219881 | PubMed |
| 2 | 25483706 | Potential impact of vaccination against Neisseria meningitidis on Neisseria gonorrhoeae in the United States: results from a decision-analysis model. | Hum Vaccin Immunother | 2014 | https://conductscience.org/library/papers/25483706 | PubMed |
| 3 | 16829618 | Understanding the immune responses to the meningococcal strain-specific vaccine MeNZB measured in studies of infants. | Clin Vaccine Immunol | 2006 | https://conductscience.org/library/papers/16829618 | PubMed |
| 4 | 15755595 | The concept of "tailor-made", protein-based, outer membrane vesicle vaccines against meningococcal disease. | Vaccine | 2005 | https://conductscience.org/library/papers/15755595 | PubMed |
| 5 | 4977280 | Human immunity to the meningococcus. I. The role of humoral antibodies. | J Exp Med | 1969 | https://conductscience.org/library/papers/4977280 | PubMed |
| 6 | 7591118 | Human antibody responses to meningococcal outer membrane antigens after three doses of the Norwegian group B meningococcal vaccine. | Infect Immun | 1995 | https://conductscience.org/library/papers/7591118 | PubMed |
| 7 | 1812432 | Vaccine against group B Neisseria meningitidis: protection trial and mass vaccination results in Cuba. | NIPH Ann | 1991 | https://conductscience.org/library/papers/1812432 | PubMed |
| 8 | 28207068 | Impact of an Immunization Campaign to Control an Increased Incidence of Serogroup B Meningococcal Disease in One Region of Quebec, Canada. | Clin Infect Dis | 2017 | https://conductscience.org/library/papers/28207068 | PubMed |
| 9 | 28686231 | Antimicrobial resistance in Neisseria gonorrhoeae: Global surveillance and a call for international collaborative action. | PLoS Med | 2017 | https://conductscience.org/library/papers/28686231 | PubMed |
| 10 | 16825336 | A universal vaccine for serogroup B meningococcus. | Proc Natl Acad Sci U S A | 2006 | https://conductscience.org/library/papers/16825336 | PubMed |
| 11 | 20844462 | Immunogenicity of two investigational serogroup B meningococcal vaccines in the first year of life: a randomized comparative trial. | Pediatr Infect Dis J | 2010 | https://conductscience.org/library/papers/20844462 | PubMed |
| 12 | 28557577 | The next chapter for group B meningococcal vaccines. | Crit Rev Microbiol | 2018 | https://conductscience.org/library/papers/28557577 | PubMed |
| 13 | 15385499 | Distribution of surface protein variants among hyperinvasive meningococci: implications for vaccine design. | Infect Immun | 2004 | https://conductscience.org/library/papers/15385499 | PubMed |
| 14 | 26192351 | The potential impact of vaccination on the prevalence of gonorrhea. | Vaccine | 2015 | https://conductscience.org/library/papers/26192351 | PubMed |
| 15 | 28705462 | Effectiveness of a group B outer membrane vesicle meningococcal vaccine against gonorrhoea in New Zealand: a retrospective case-control study. | Lancet | 2017 | https://conductscience.org/library/papers/28705462 | PubMed |
| 16 | 1682541 | Effect of outer membrane vesicle vaccine against group B meningococcal disease in Norway. | Lancet | 1991 | https://conductscience.org/library/papers/1682541 | PubMed |
| 17 | 17227687 | Induction of secretory immunity and memory at mucosal surfaces. | Vaccine | 2007 | https://conductscience.org/library/papers/17227687 | PubMed |
| 18 | 17898183 | Immunogenicity, reactogenicity, and safety of a P1.7b,4 strain-specific serogroup B meningococcal vaccine given to preteens. | Clin Vaccine Immunol | 2007 | https://conductscience.org/library/papers/17898183 | PubMed |
| 19 | 17615088 | A prospective study of the effectiveness of the New Zealand meningococcal B vaccine. | Am J Epidemiol | 2007 | https://conductscience.org/library/papers/17615088 | PubMed |
| 20 | 17494636 | Seroprevalence of bactericidal and anti-outer membrane vesicle antibodies to Neisseria meningitidis group B in England. | Clin Vaccine Immunol | 2007 | https://conductscience.org/library/papers/17494636 | PubMed |
Cited by42
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 57 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42373756 | New insights into outer membrane vesicles in Gram-negative bacteria from biogenesis to applications. | Commun Biol | 2026 | https://conductscience.org/library/papers/42373756 | PubMed |
| 42343418 | Bacterial extracellular vesicles modulate epithelial antiviral responses via macrophage-mediated immunomodulation. | Cell Commun Signal | 2026 | https://conductscience.org/library/papers/42343418 | PubMed |
| 42321851 | Extracellular vesicles in solid tumors: from tumor ecology to engineered therapeutics. | Mol Cancer | 2026 | https://conductscience.org/library/papers/42321851 | PubMed |
| 41900446 | Bacterial Membrane Vesicles: Biogenesis, Functions, and Emerging Biotechnological Applications. | Microorganisms | 2026 | https://conductscience.org/library/papers/41900446 | PubMed |
| 41810466 | From bench to bedside: Unveiling the background and benefits of nanovaccines tested in clinics. | Asian J Pharm Sci | 2026 | https://conductscience.org/library/papers/41810466 | PubMed |
| 41572344 | Bacterial outer membrane vesicles: a smart platform for biomedical applications. | Cell Commun Signal | 2026 | https://conductscience.org/library/papers/41572344 | PubMed |
| 41169343 | Two Sides of the Same Coin-Mechanistic Insight, Diagnostic Application and Therapeutic Translation of Bacterial and Host-Derived Extracellular Vesicles. | J Extracell Biol | 2025 | https://conductscience.org/library/papers/41169343 | PubMed |
| 41050659 | Gut microbiota: a promising new target in immune tolerance. | Front Immunol | 2025 | https://conductscience.org/library/papers/41050659 | PubMed |
| 40617825 | A novel GMMA-based gonococcal vaccine demonstrates functional immune responses in mice. | NPJ Vaccines | 2025 | https://conductscience.org/library/papers/40617825 | PubMed |
| 40430807 | Genetic and Antigenic Diversity of Neisseria meningitidis Serogroup B Strains in Vietnam. | Pathogens | 2025 | https://conductscience.org/library/papers/40430807 | PubMed |
| 40192813 | Optimization of methods for isolation and purification of outer membrane vesicles (OMVs) from Neisseria lactamica. | Appl Microbiol Biotechnol | 2025 | https://conductscience.org/library/papers/40192813 | PubMed |
| 39923096 | RBD-displaying OMV nanovaccine boosts immunity against SARS-CoV-2. | J Nanobiotechnology | 2025 | https://conductscience.org/library/papers/39923096 | PubMed |
| 38939213 | Large-scale production of extracellular vesicles: Report on the "massivEVs" ISEV workshop. | J Extracell Biol | 2022 | https://conductscience.org/library/papers/38939213 | PubMed |
| 38773507 | Outer membrane vesicles generated by an exogenous bacteriophage lysin and protection against Acinetobacter baumannii infection. | J Nanobiotechnology | 2024 | https://conductscience.org/library/papers/38773507 | PubMed |
| 38289395 | Modelling of doxycycline-based prevention of bacterial sexually transmitted infections in comparison to condom-based and test-based prevention. | Eur J Microbiol Immunol (Bp) | 2024 | https://conductscience.org/library/papers/38289395 | PubMed |
| 37651146 | Association of Group B Meningococcal Vaccine Receipt With Reduced Gonorrhea Incidence Among University Students. | JAMA Netw Open | 2023 | https://conductscience.org/library/papers/37651146 | PubMed |
| 37223254 | Outer membrane vesicles as versatile tools for therapeutic approaches. | Microlife | 2021 | https://conductscience.org/library/papers/37223254 | PubMed |
| 37222309 | Exploring the performance of Escherichia coli outer membrane vesicles as a tool for vaccine development against Chagas disease. | Mem Inst Oswaldo Cruz | 2023 | https://conductscience.org/library/papers/37222309 | PubMed |
| 37080941 | Engineering Extracellular Vesicles as Delivery Systems in Therapeutic Applications. | Adv Sci (Weinh) | 2023 | https://conductscience.org/library/papers/37080941 | PubMed |
| 36986523 | Endogenous Lipid Carriers-Bench-to-Bedside Roadblocks in Production and Drug Loading of Exosomes. | Pharmaceuticals (Basel) | 2023 | https://conductscience.org/library/papers/36986523 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/29048985
GET https://conductscience.org/api/papers/v1/29048985/references?page=2